摘要 : Introduction: Neuroblastoma accounts for 8-10% of pediatric cancers and is responsible for 15% of childhood cancer deaths. Despite multimodality treatment, the overall survival (OS) and event-free survival (EFS) in high-risk patie... 展开
作者 | Castel~V. Segura~V. Berlanga~P. |
---|---|
作者单位 | |
期刊名称 | 《Expert opinion on emerging drugs》 |
总页数 | 17 |
语种/中图分类号 | 英语 / R9 |
关键词 | Cancer in children Drug development Immunotherapy Neuroblastoma Target therapy |
馆藏号 | N2007EPST0001715 |